Juvenile myoclonic epilepsy — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Sodium valproate
Sodium valproate is the most effective first-line treatment for juvenile myoclonic epilepsy (JME). JME is a lifelong condition requiring ongoing treatment. Carbamazepine and phenytoin should be avoided as they may worsen myoclonic and absence seizures. In females of childbearing age, levetiracetam or lamotrigine is preferred due to valproate teratogenicity.
Reference: Australian Therapeutic Guidelines – 2024 – Neurology; RACP Paediatric Curriculum – Neurology